TR60 60mg*10vials

Tirzepatide TR60 60mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing an ultra-high-concentration metabolic research compound that activates two gut hormone pathways simultaneously.

The 60mg single-vial specification offers an extremely high active ingredient load per vial, well-suited for ultra-long-term large animal studies, extreme high-dose validation experiments, and very large-scale multi-group parallel research projects. The high concentration minimizes the number of vials required for extended experiments, reducing operational errors and data variability from repeated dilution and solution changes.

Through combined GLP-1 and GIP receptor activation, this compound supports advanced research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides a comprehensive scope for studying systemic metabolic regulation under high-dose experimental conditions.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for high-intensity preclinical research and large-scale laboratory operations.